Literature DB >> 19174525

CD5 sweetens lymphocyte responses.

Laurel L Lenz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19174525      PMCID： PMC2635820          DOI： 10.1073/pnas.0812579106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.

Authors:  Idoia Gimferrer; Montse Farnós; Maria Calvo; María Mittelbrunn; Carlos Enrich; Francisco Sánchez-Madrid; Jordi Vives; Francisco Lozano
Journal:  J Biol Chem       Date:  2002-12-08       Impact factor: 5.157

3.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

Authors:  Stephanie Dillon; Sudhanshu Agrawal; Kaustuv Banerjee; John Letterio; Timothy L Denning; Kyra Oswald-Richter; Deborah J Kasprowicz; Kathryn Kellar; Jeff Pare; Thomas van Dyke; Steven Ziegler; Derya Unutmaz; Bali Pulendran
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

4.  Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments.

Authors:  Benjamin N Gantner; Randi M Simmons; David M Underhill
Journal:  EMBO J       Date:  2005-02-24       Impact factor: 11.598

5.  CD5 inhibits signaling at the immunological synapse without impairing its formation.

Authors:  Cédric Brossard; Monique Semichon; Alain Trautmann; Georges Bismuth
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 6.  beta-Glucans and dectin-1.

Authors:  S Vicky Tsoni; Gordon D Brown
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  A role for CD5 in TCR-mediated signal transduction and thymocyte selection.

Authors:  A Tarakhovsky; S B Kanner; J Hombach; J A Ledbetter; W Müller; N Killeen; K Rajewsky
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

8.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

9.  Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.

Authors:  T M Hohl; M Feldmesser; D S Perlin; E G Pamer
Journal:  J Infect Dis       Date:  2008-07-15       Impact factor: 5.226

10.  CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Authors:  Maria-Rosa Sarrias; Montserrat Farnós; Rubén Mota; Fernando Sánchez-Barbero; Anna Ibáñez; Idoia Gimferrer; Jorge Vera; Rafael Fenutría; Cristina Casals; José Yélamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-29       Impact factor: 11.205
View more
  8 in total

1.  CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.

Authors:  P Nair; R Melarkode; D Rajkumar; E Montero
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 2.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

Review 3.  Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase.

Authors:  Edwin J Vazquez-Cintron; Ngozi R Monu; Alan B Frey
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

4.  The Lymphocytic Scavenger Receptor CD5 Shows Therapeutic Potential in Mouse Models of Fungal Infection.

Authors:  María Velasco-de Andrés; Cristina Català; Sergi Casadó-Llombart; Mario Martínez-Florensa; Inês Simões; Joaquín García-Luna; Gustavo Mourglia-Ettlin; Óscar Zaragoza; Esther Carreras; Francisco Lozano
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.

Authors:  Anders Rosén; Ann-Charlotte Bergh; Peter Gogok; Chamilly Evaldsson; Anna Lanemo Myhrinder; Eva Hellqvist; Abu Rasul; Magnus Björkholm; Mattias Jansson; Larry Mansouri; Anquan Liu; Bin Tean Teh; Richard Rosenquist; Eva Klein
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

6.  Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses.

Authors:  Rafael Fenutría; Vanesa G Martinez; Inês Simões; Jorge Postigo; Victor Gil; Mario Martínez-Florensa; Jordi Sintes; Rodrigo Naves; Kevin S Cashman; José Alberola-Ila; Manel Ramos-Casals; Gloria Soldevila; Chander Raman; Jesús Merino; Ramón Merino; Pablo Engel; Francisco Lozano
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 7.  Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.

Authors:  María Velasco-de Andrés; Sergi Casadó-Llombart; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Fernando Aranda
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

8.  CD6 deficiency impairs early immune response to bacterial sepsis.

Authors:  Cristina Català; María Velasco-de Andrés; Alejandra Leyton-Pereira; Sergi Casadó-Llombart; Manuel Sáez Moya; Rebeca Gutiérrez-Cózar; Joaquín García-Luna; Marta Consuegra-Fernández; Marcos Isamat; Fernando Aranda; Mario Martínez-Florensa; Pablo Engel; Gustavo Mourglia-Ettlin; Francisco Lozano
Journal:  iScience       Date:  2022-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.